explore
Previous article:
How one medical school became remarkably diverse
Next article: Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more
Next article: Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more
leisure time
explore
-
Appeals court upholds limits to abortion pill
2025-08-26 09:43 -
What we’ve learned from the Aduhelm mess
2025-08-26 09:32 -
PhRMA lawsuit over Medicare drug price negotiation tossed
2025-08-26 08:50 -
In science, is the line between industry and academia shifting?
2025-08-26 08:40 -
What should King Charles tell the public about his cancer?
2025-08-26 08:22 -
Vaccine advisory panel ACIP left half staffed by HHS
2025-08-26 08:14